Scenarios that move NBIX
Neurocrine Biosciences, Inc. - Common Stock
Scenarios that move NBIX: 4 analyses, 4 positive, 0 negative.
- · uniQure plunges after additional Huntington's disease study data — ▲ · impact +26 · confidence high · horizon quarters
- · Xenon files epilepsy NDA as depression study setback weighs — ▲ · impact +12 · confidence low · horizon quarters
- · Definium reports second Phase III success in anxiety program — ▲ · impact +45 · confidence low · horizon weeks
- · Ascendis announces planned $400 million share repurchase program — ▲ · impact +8 · confidence low · horizon quarters